THE USE OF CABERGOLINE IN CHILDREN AND ADOLESCENTS WITH HYPERPROLACTINEMIA SYNDROME
- Authors: Zhurtova I.B.1, Strebkova N.A.1, Zhurtova IB1, Strebkova NA1
-
Affiliations:
- Issue: No 3 (2012)
- Pages: 81-85
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279303
- ID: 279303
Cite item
Full Text
Abstract
Prolactin secreting tumors are very rare among children, than in adults. Although treatment strategies for prolactinomas in adults are well established and at present time the preference is given to dopamine agonists, the use of these drugs in pediatric patients is limited due to lack of information on safety and efficiency in this group of patients. Cabergoline is a drug of choice for treatment adult patients with prolactinomas. This clinical material demonstrates high efficacy and good tolerability of cabergoline in children and adolescents with prolactinomas and idiopathic hyperprolactinemia. It will allow in future to refrain from surgical treatment and reduce the number of patients with postoperative complications.
Keywords
About the authors
Inessa Borisovna Zhurtova
Natal'ya Anatol'evna Strebkova
I B Zhurtova
N A Strebkova
References
- Sedda A, Meyer P. Management of prolactinomas: what's new in 2010? Rev Med Suisse 2011;7(277):20-4.
- Bhansali A, Walia R, Dutta P, et al. Efficacy of cabergoline on rapid escalation of dose in men with macroprolactinomas. Ind J Med Res 2010;131:530-5.
- Ono M, Miki N, Amano K, et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab 2010;95(6):2672-79.
- Vilar L, Naves LA, Casulari LA, et al. Management of prolactinomas in Brazil: an electronic survey. Pituitary 2010;13(3):199-206.
- Cho EH, Lee SA, Chung JY, Koh EH, et al. Source Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma. J Korean Med Sci 2009;24(5):874-78.
- Dekkers OM, Lagro J, Durman P, et al. Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. J Clin Endocrinol Metab 2010;95(1):43-51.
Supplementary files
